From Medscape HIV/AIDS

Coverage from the

International AIDS Society (IAS) 2017 Conference

July 23 - 26, 2017; Paris, France

July 23 - 26, 2017 Paris, France

Conference News

Popular News from AIDS 2016

  • Long-Acting Injectable Antiretroviral Safe, Effective Long-Acting Injectable Antiretroviral Safe, Effective The first long-acting injectable antiretroviral regimen is safe and effective at 48 weeks, and patients find it very convenient, new research suggests.
  • HIV Vaccine Trial Gets Green Light HIV Vaccine Trial Gets Green Light Immune responses to candidate HIV vaccines in a South African population were so robust that a large phase 2b/3 efficacy trial will be launched.
  • Latest HIV Cure Data Expose Resilience of Infection Latest HIV Cure Data Expose Resilience of Infection Disappointing results from SEARCH 19 and other recent studies are a challenge for researchers, who must balance progress with the fact that most patients are doing well on antiretroviral therapy.

Medscape HIV/AIDS©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

 

Previous Coverage

https://pillsbank.net

Левитра 60 мг

https://pillsbank.net